Skin Elements (ASX:SKN) Total Assets: A$2.01 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Skin Elements Total Assets?

Skin Elements ASX:SKN Total Assets is A$2.01 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Skin Elements's Total Assets for the quarter that ended in Dec. 2025 was A$2.01 Mil.

During the past 12 months, Skin Elements's average Total Assets Growth Rate was -42.10% per year. During the past 3 years, the average Total Assets Growth Rate was -60.70% per year. During the past 5 years, the average Total Assets Growth Rate was -47.50% per year.

During the past 9 years, Skin Elements's highest 3-Year average Total Assets Growth Rate was 3.50%. The lowest was -62.10%. And the median was -3.10%.

Total Assets is connected with ROA %. Skin Elements's annualized ROA % for the quarter that ended in Dec. 2025 was -587.55%. Total Assets is also linked to Revenue through Asset Turnover. Skin Elements's Asset Turnover for the quarter that ended in Dec. 2025 was 0.13.

Skin Elements  (ASX:SKN) Total Assets Explanation

Total Assets is connected with ROA %.

Skin Elements's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-8.02/( (0.72+2.01)/ 2 )
=-8.02/1.365
=-587.55 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Skin Elements's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.184/( (0.72+2.01)/ 2 )
=0.184/1.365
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Skin Elements Total Assets Related Terms

Skin Elements Total Assets Historical Data

* Premium members only.

The historical data trend for Skin Elements's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skin Elements Total Assets Chart

Skin Elements Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
Get a 7-Day Free Trial Premium Member Only 11.53 12.10 9.18 0.75 0.72

Skin Elements Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.75 0.54 0.72 2.01

Skin Elements Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Skin Elements's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=-1.937+2.657
=0.72

Skin Elements's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=1.581+0.429
=2.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of A$2.01 Mil mean?
Skin Elements (ASX:SKN) has a Total Assets of A$2.01 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Skin Elements and its competitors.
Is Skin Elements' Total Assets too high?
Skin Elements' current Total Assets is A$2.01 Mil.
How does Skin Elements' Total Assets compare to PG and CL?
Skin Elements' Total Assets of A$2.01 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Skin Elements and its competitors. Skin Elements's current Total Assets is A$2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Elements stock overvalued right now?
Skin Elements (ASX:SKN) has a current Total Assets of A$2.01 Mil. The current Total Assets is A$2.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Skin Elements (ASX:SKN), the current Total Assets is A$2.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skin Elements Business Description

Address 1255A Hay Street, West Perth, Perth, WA, AUS, 6005
Skin Elements Ltd is a company that operates in the beauty and personal care industry. The principal business activities include the manufacture and distribution of natural, organic, health, and wellness products. Its brand portfolio includes Soleo Organics natural sunscreen brand, the PapayaActivs therapeutic skincare range, Elizabeth Jane Natural Cosmetics, and the recently developed Invisi-Shield SuprCuvr plant-based hospital-grade disinfectant range. The company has a single segment being research and development of the inventive proprietary SE Formula biotechnology.